A Phase 3, Multinational, Long-term Follow-up Study to Evaluate Safety and Efficacy in Subjects Who Have Previously Received SRP-9001 in a Clinical Study
A Phase 3, Multinational, Long-term Follow-up Study to Evaluate Safety and Efficacy in Subjects Who Have Previously Received SRP-9001 in a Clinical Study
The purpose of this study is to provide a single clinical study with a uniform approach to monitoring long-term safety and efficacy in participants who received delandistrogene moxeparvovec in a previous clinical study. No study drug will be administered as part of this study.
Inclusion Criteria:
Exclusion Criteria:
Ghent, East Flanders 9000, Belgium
Essen, North Rhine-Westphalia 45147, Germany
Genova, 16147, Italy
Roma, 00168, Italy
London, Greater London WC1N 1EJ, United Kingdom